BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34206779)

  • 1. Sensory Reactivity Phenotype in Phelan-McDermid Syndrome Is Distinct from Idiopathic ASD.
    Tavassoli T; Layton C; Levy T; Rowe M; George-Jones J; Zweifach J; Lurie S; Buxbaum JD; Kolevzon A; Siper PM
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34206779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: Sensory Reactivity in Children with Phelan-McDermid Syndrome.
    Mieses AM; Tavassoli T; Li E; Soorya L; Lurie S; Wang AT; Siper PM; Kolevzon A
    J Autism Dev Disord; 2016 Jul; 46(7):2508-13. PubMed ID: 26914612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
    Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR
    J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations.
    Oberman LM; Boccuto L; Cascio L; Sarasua S; Kaufmann WE
    Orphanet J Rare Dis; 2015 Aug; 10():105. PubMed ID: 26306707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes.
    Xu N; Lv H; Yang T; Du X; Sun Y; Xiao B; Fan Y; Luo X; Zhan Y; Wang L; Li F; Yu Y
    Orphanet J Rare Dis; 2020 Nov; 15(1):335. PubMed ID: 33256793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by
    De Rubeis S; Siper PM; Durkin A; Weissman J; Muratet F; Halpern D; Trelles MDP; Frank Y; Lozano R; Wang AT; Holder JL; Betancur C; Buxbaum JD; Kolevzon A
    Mol Autism; 2018; 9():31. PubMed ID: 29719671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus recommendations on altered sensory functioning in Phelan-McDermid syndrome.
    Walinga M; Jesse S; Alhambra N; ; Van Buggenhout G
    Eur J Med Genet; 2023 May; 66(5):104726. PubMed ID: 36796507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder.
    Richards C; Powis L; Moss J; Stinton C; Nelson L; Oliver C
    J Neurodev Disord; 2017 Nov; 9(1):37. PubMed ID: 29126394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinician-administered observation and corresponding caregiver interview capturing DSM-5 sensory reactivity symptoms in children with ASD.
    Siper PM; Kolevzon A; Wang AT; Buxbaum JD; Tavassoli T
    Autism Res; 2017 Jun; 10(6):1133-1140. PubMed ID: 28296264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gait Abnormalities in Children with Phelan-McDermid Syndrome.
    Frank Y; Levy T; Lozano R; Friedman K; Underwood S; Kostic A; Walker H; Kolevzon A
    J Child Neurol; 2023 Dec; 38(13-14):665-671. PubMed ID: 37849292
    [No Abstract]   [Full Text] [Related]  

  • 11. Social visual attentional engagement and memory in Phelan-McDermid syndrome and autism spectrum disorder: a pilot eye tracking study.
    Guillory SB; Baskett VZ; Grosman HE; McLaughlin CS; Isenstein EL; Wilkinson E; Weissman J; Britvan B; Trelles MP; Halpern DB; Buxbaum JD; Siper PM; Wang AT; Kolevzon A; Foss-Feig JH
    J Neurodev Disord; 2021 Dec; 13(1):58. PubMed ID: 34863106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual Evoked Potential Abnormalities in Phelan-McDermid Syndrome.
    Siper PM; Rowe MA; Guillory SB; Rouhandeh AA; George-Jones JL; Tavassoli T; Lurie S; Zweifach J; Weissman J; Foss-Feig J; Halpern D; Trelles MP; Mulhern MS; Brittenham C; Gordon J; Zemon V; Buxbaum JD; Kolevzon A
    J Am Acad Child Adolesc Psychiatry; 2022 Apr; 61(4):565-574.e1. PubMed ID: 34303785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.
    Costales JL; Kolevzon A
    Neurotherapeutics; 2015 Jul; 12(3):620-30. PubMed ID: 25894671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.
    Schön M; Lapunzina P; Nevado J; Mattina T; Gunnarsson C; Hadzsiev K; Verpelli C; Bourgeron T; Jesse S; van Ravenswaaij-Arts CMA; ; Hennekam RC
    Eur J Med Genet; 2023 Jul; 66(7):104754. PubMed ID: 37003575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genetic Aspects of Phelan-McDermid Syndrome: An Interdisciplinary Approach to Management.
    Cammarata-Scalisi F; Callea M; Martinelli D; Willoughby CE; Tadich AC; Araya Castillo M; Lacruz-Rengel MA; Medina M; Grimaldi P; Bertini E; Nevado J
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome.
    Fastman J; Foss-Feig J; Frank Y; Halpern D; Harony-Nicolas H; Layton C; Sandin S; Siper P; Tang L; Trelles P; Zweifach J; Buxbaum JD; Kolevzon A
    Mol Autism; 2021 Sep; 12(1):62. PubMed ID: 34593045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism.
    Breen MS; Browne A; Hoffman GE; Stathopoulos S; Brennand K; Buxbaum JD; Drapeau E
    Mol Autism; 2020 Jun; 11(1):53. PubMed ID: 32560742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.
    Disciglio V; Lo Rizzo C; Mencarelli MA; Mucciolo M; Marozza A; Di Marco C; Massarelli A; Canocchi V; Baldassarri M; Ndoni E; Frullanti E; Amabile S; Anderlid BM; Metcalfe K; Le Caignec C; David A; Fryer A; Boute O; Joris A; Greco D; Pecile V; Battini R; Novelli A; Fichera M; Romano C; Mari F; Renieri A
    Am J Med Genet A; 2014 Jul; 164A(7):1666-76. PubMed ID: 24700646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral Phenotyping of an Improved Mouse Model of Phelan-McDermid Syndrome with a Complete Deletion of the
    Drapeau E; Riad M; Kajiwara Y; Buxbaum JD
    eNeuro; 2018; 5(3):. PubMed ID: 30302388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neurological Manifestations of Phelan-McDermid Syndrome.
    Frank Y
    Pediatr Neurol; 2021 Sep; 122():59-64. PubMed ID: 34325981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.